Arab Board OB/GYN Final Clinical & Oral flashcards
Arab Board OB/GYN Final Clinical & Oral · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Nuchal translucency
- Fluid collection at the fetal neck measured by ultrasound at 11+0 to 13+6 weeks; increased thickness raises the risk of aneuploidy and structural anomalies.
- Preeclampsia severe features
- Blood pressure at least 160/110 mmHg, low platelets, elevated liver enzymes, renal impairment, pulmonary edema, or cerebral or visual symptoms requiring urgent management.
- Anti-D prophylaxis
- Anti-D immunoglobulin given to RhD-negative unsensitized women around 28 weeks and within 72 hours of delivery of an RhD-positive infant to prevent alloimmunization.
- Fetal growth restriction
- Estimated fetal weight below the 10th centile with evidence of placental insufficiency such as abnormal umbilical artery Doppler, raising risks of stillbirth and neonatal morbidity.
- Active first stage
- The phase from about 5 cm cervical dilatation to full dilatation, during which progress is typically assessed at roughly 0.5 to 1 cm per hour.
- Tachysystole
- More than five contractions in ten minutes averaged over thirty minutes; oxytocin should be reduced or stopped and tocolysis considered if fetal status is abnormal.
- Shoulder dystocia maneuvers
- Sequence including McRoberts position, suprapubic pressure, internal rotation, and delivery of the posterior arm; fundal pressure is avoided because it worsens impaction.
- Cord prolapse management
- Elevate the presenting part, place the woman in knee-chest or Trendelenburg position, fill the bladder, and arrange immediate delivery while minimizing cord compression.
- Primary postpartum hemorrhage
- Blood loss of 500 mL or more after vaginal birth or 1000 mL or more after cesarean birth, or any loss producing hemodynamic instability; uterine atony is the commonest cause.
- Tranexamic acid in hemorrhage
- An antifibrinolytic given as 1 g intravenously within three hours of postpartum hemorrhage onset; it reduces death from bleeding and is given alongside uterotonics.
- Magnesium sulfate for eclampsia
- Loading dose of 4 to 6 g intravenously followed by 1 to 2 g per hour; recurrent seizures receive a further 2 g bolus with monitoring of reflexes and respiration.
- Secondary postpartum hemorrhage
- Bleeding from 24 hours to 12 weeks after birth, usually due to retained placental tissue or endometritis; ultrasound and antibiotics with evacuation if tissue is retained.
- PALM-COEIN classification
- FIGO system for abnormal uterine bleeding: polyp, adenomyosis, leiomyoma, malignancy or hyperplasia versus coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, and not otherwise classified.
- Postmenopausal bleeding evaluation
- Any bleeding after menopause requires endometrial sampling; transvaginal ultrasound endometrial thickness of 4 mm or less has high negative predictive value in low-risk women.
- Ovarian torsion
- Sudden unilateral pelvic pain with nausea; Doppler flow may be normal, so clinical suspicion warrants prompt laparoscopy to preserve the ovary.
- Bartholin gland abscess
- Painful vulvar swelling treated by incision and drainage with a Word catheter or marsupialization; biopsy is advised in women over 40 to exclude malignancy.
- Endometrial cancer risk factors
- Obesity, nulliparity, unopposed estrogen exposure, tamoxifen use, and Lynch syndrome; postmenopausal bleeding is the cardinal presenting symptom.
- Risk of malignancy index
- Score combining CA-125, menopausal status, and ultrasound features used to triage adnexal masses for referral to a gynecologic oncology center.
- Complete hydatidiform mole
- Gestational trophoblastic disease with higher malignant potential than partial mole; serial beta-hCG monitoring detects persistent disease and methotrexate treats low-risk cases.
- BRCA risk-reducing surgery
- Salpingo-oophorectomy offered after childbearing, around age 35 to 40 for BRCA1 and 40 to 45 for BRCA2 carriers, to reduce ovarian and breast cancer risk.
- Infertility definition
- Failure to conceive after twelve months of regular unprotected intercourse; earlier investigation is warranted if age is 35 or older, cycles are irregular, or pathology is known.
- Ovulation confirmation
- A mid-luteal serum progesterone above about 16 nmol/L or 3 ng/mL indicates that ovulation has occurred during that cycle.
- Letrozole ovulation induction
- Aromatase inhibitor used as first-line ovulation induction in polycystic ovary syndrome, with higher live birth rates and fewer multiple pregnancies than clomiphene.
- Premature ovarian insufficiency
- Loss of ovarian function before age 40; hormone replacement therapy is continued until at least the usual age of menopause to protect bone and cardiovascular health.
- POP-Q staging
- Pelvic organ prolapse quantification system with stages 0 to IV; stage II reaches within 1 cm of the hymen, stage III extends beyond it, and stage IV is complete eversion.
- Stress urinary incontinence
- Involuntary leakage of urine on effort, sneezing, or coughing; first-line treatment is pelvic floor muscle training for at least three months before surgery.
- Obstetric anal sphincter injury
- Third-degree tears involve the anal sphincter and fourth-degree tears involve the anal epithelium; experienced repair and follow-up reduce later fecal incontinence.
- Pessary for prolapse
- A removable vaginal device used as first-line conservative treatment for prolapse or incontinence, particularly in older or frail women, with regular follow-up for erosion.
- Migraine with aura and estrogen
- Combined hormonal contraception is contraindicated because of increased ischemic stroke risk; progestogen-only methods are preferred in these women.
- Copper intrauterine device
- Emergency contraceptive effective up to five days after unprotected intercourse and a long-acting reversible method with typical use failure below one percent.
- Lactational amenorrhea method
- Effective contraception only when the woman is under six months postpartum, fully breastfeeding, and remains amenorrheic; otherwise another method is needed.
- Informed consent elements
- Capacity, adequate disclosure of material risks and alternatives, understanding of the information, and voluntary agreement; the discussion should be documented in the record.